Glutathione s transferases (GSTs) consist of a superfamily of dimeric phase II metabolic enzymes that catalyse the conjugation of reduced glutathione with various electrophilic compounds ([@B1]). The human *GST* genes are divided into four major subfamilies designated as *GST*α or A, *GST*µ or *M*, *GST*θ or *T*, and *GST*π or *P* ([@B2]). The class π*GST* gene exists as a single functional gene in human, whereas class α, µ, and θ families contain multiple distinct genes, sharing \~55, 65, and 50% identity, respectively ([@B3]). Two of these subfamilies, *GSTM1* and *GSTT1*, show deletion polymorphism ([@B4]), and the *GSTP1* gene has polymorphism loci within its coding region, of which well-known are an A- to -G transition at nucleotide position 1,578 causing an isoleucine-to-valine substitution at codon 105 (Ile^105^Val) in exon 5, a C- to -T base change at position 2,293 giving rise to the replacement of alanine to valine at the amino acid position 114 (Ala^114^Val) in exon 6 ([@B5], [@B6]).

Human cytosolic GSTs have been well characterized and known to be polymorphic, with different polymorphism frequencies by ethnicity. The percentage of individuals who do not express the GSTM1 enzyme due to a homozygous gene deletion is higher in Caucasians and Asians than in Africans ([@B7], [@B8]). About 60% of Asians, 40% of Africans and 20% of Caucasians do not express the GSTT1 enzyme ([@B9]). These homozygous gene deletions, called null genotypes, are denoted as *GSTM1*\**0*/\**0* and *GSTT1*\**0*/\**0*. Polymorphisms of *GSTM1*, *GSTT1*, and *GSTP1* have been shown to be associated with susceptibility to various forms of cancer, particular those caused by cigarette smoking ([@B9]), resistance to chemotherapy treatment ([@B3]), and disease outcomes ([@B10]). We analyzed the frequencies of the major polymorphisms of *GSTM1*, *GSTT1* and *GSTP1* in a Korean male population to provide a basic database for future clinical and genetic studies concerning variability in the response and/or toxicity to drugs known to be substrates for GSTs.

The study subjects are healthy individuals recruited from the health promotion center, Samsung Medical Center without any pathology. A total of 1,051 unrelated male Korean subjects (mean age, 50.7 yr; range, 35-76 yr) participated in this study. Deletion status of *GSTM1* and *GSTT1* was simultaneously determined by a multiplex polymerase chain reaction method ([@B11]). *GSTM1* and *GSTT1* genes were amplified using the following primers: 5\'GAA CTC CCT GAA AAG CTA AAG C 3\'and 5\'GTT GGG CTC AAA TAT ACG GTG G 3\'for *GSTM1* and 5\'TTC CTT ACT GGT CCT CAC ATC TC 3\'and 5\'TCA CCG GAT CAT GGC CAG CA 3\'for *GSTT1*. As an internal control, exon 7 of the *CYP1A1* gene was co-amplified using the primers 5\'GAA CTG CCA GGC CAG CA 3\'and 5\'CAG CTG CAT TTG GAA GTG CTC 3\'. Agarose gel electrophoresis (1%) resolved amplified DNA fragments of 480, 312, and 215 bp for *GSTT1*, *CYP1A1* and *GSTM1*, respectively. To determine the genotypes at codon 105 and 114, respectively, the exon 5 and exon 6 of the *GSTP1* gene were amplified using the following primers: 5\'TGT GTG GCA GTC TCT CAT CC 3\'and 5\'GAA GCC CCT TTC TTG TTC A 3\'for the exon 5 and 5\'GCAAGCAGAGGAGAA TCT GG 3\'and 5\'CTA AGC CCA TCC CCT AGG TC 3\'for the exon 6, and directly sequenced on ABI Prism 3,700 Genetic analyzer (Applied Biosystems, Foster City, CA, U.S.A.) using the ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems).

The null *GSTM1* and *GSTT1* genotypes were found in 53.8% and 54.3% of the individuals, respectively. Twenty-nine percent had the null genotype for both genes. The only genetic polymorphism in *GSTP1* was Ile^105^Val in exon 5. The genotype distribution of this locus was Ile~105~/Ile~105~ in 68.4%, Ile~105~/Val~105~ in 29.1%, and Val~105~/Val~105~ in 2.5%, which is in Hardy-Weinberg equilibrium by χ^2^ test. The allele frequency of Ile at codon 105 was 0.83. We examined the distribution and frequencies of the combined genotypes of *GSTM1*, *GSTP1* and *GSTM1*. For genotype combination analysis, there were 1,021 samples available where the genotyping was successful for each of three *GST* genes. Eleven out of 12 possible combinations were observed ([Table 1](#T1){ref-type="table"}). Five genotype combinations showed frequencies greater than 10%. The most frequently observed combination was Null type/Ile~105~/Ile~105~/Null type, while Non-null type/Val~105~/Val~105~/Non-Null type was not observed.

Polymorphisms in *GST* genes can affect the expression levels of the GST enzymes. Since GST enzymes play a vital role in cellular defense against environmentally toxic compounds, such as carcinogens, polymorphisms of *GST* gene can increase subsceptibility to diseases caused by such xenobiotics. We observed 53.8% of the Korean population were homozygous for the *GSTM1* deletion. This frequency is similar to that reported in a previous study that analyzed the *GSTM1* polymorphism in Koreans ([@B12], [@B13]) and also to those reported in other studies in Caucasians and Japanese ([Table 2](#T2){ref-type="table"}) ([@B14], [@B15]). We observed 54.3% of these Koreans were homozygous for the *GSTT1* deletion. This frequency is similar to that reported in other studies that analyzed the *GSTT1* polymorphism in Koreans and Japanese ([@B12], [@B15]), however higher than that observed in Caucasian population ([Table 2](#T2){ref-type="table"}) ([@B7], [@B14], [@B16]). The frequency of double nulls observed in the present study (29.1%) is higher than that observed in a Caucasian population ([@B14]), South Indians, and Afro-Americans ([@B17]). No frequency data are available for double nulls in other Asians including Japanese and Chinese, and Koreans. Three different *GSTP1* alleles, *GSTP1a*, *GSTP1b*, and *GSTP1c*, have been described ([@B6]). *GSTP1b* differs from *GSTP1a* by having an A→G transition at nucleotide +313, changing codon 105 from ATG (Ile) to GTC (Val). *GSTP1c* is characterized by two nucleotide transitions, A→G at +313, the same as observed in *GSTP1b*, and C→T at +341, changing codon 114 from GCG (Ala) to GTG (Val) ([@B5]). In this study, we observed 68.4% had the Ile~105~/Ile~105~ genotype, 29.1% had the Ile~105~/Val~105~ genotype, and 2.5% had the Val~105~/Val~105~ genotype, with an allelic frequency 0.83 for the Ile allele. The polymorphism GCG (Ala)→GTG (Val) at codon 114 was not observed. These results are similar to those reported in other studies in Koreans ([@B18]) and other Asians ([@B19], [@B20]). The Val~105~/Val~105~ genotype was more frequent in Caucasians than in Asians ([Table 3](#T3){ref-type="table"}) ([@B21]). Little has been known about the combined effect of the *GSTM1*, *GSTT1*, and *GSTP1* genotypes. For all three polymorphisms, previous studies reported association with various diseases, however subsequent studies validating these findings are lacking. Recent reports and meta-analysis show that single *GST* gene polymorphisms do not significantly increase risks to various diseases ([@B22]-[@B24]), suggesting investigations on combined genotypes of *GSTM1*, *GSTT1* and *GSTP1*, or even in relation to other metabolizing enzymes are needed. Several studies have reported a relationship between combination of the *GST* genotype and risk of various diseases such as chronic lymphocytic leukemia, thyroid cancer and breast cancer ([@B25]-[@B27]) and some of them suggested a possible synergistic effect between *GST* genotypes ([@B25], [@B27]). In present study concerning combination of the *GSTM1*, *GSTP1* and *GSTT1* genotypes, noteworthy points are lack of Non-null type/Val~105~/Val~105~/Non-Null type and presence of Null type/Val~105~/Val~105~/Null type. Although finding might need further confirmation in other healthy populations, it suggests a potential difference in genetic susceptibility to various diseases in Korean population. Although our study included only male subjects, given that the genotype frequencies are not affected by sex in general ([@B28]), our data can represent the population genotype frequencies. Indeed, our data did not show any significant differences when compared with other studies that included female subjects ([@B13], [@B28]).

In conclusion, genotype data for polymorphic variants of *GST* genes provide further evidence for ethnic variations in metabolism and disposition. The notable merit of this study is that we genotyped all three major GST enzymes, GSTM1, GSTP1, and GSTT1, in the largest population studied, reporting the frequency distribution of the combined genotypes. We believe these data will help genetic studies on *GSTM1*, *GSTT1* and *GSTP1* polymorphisms in association with disease risks and drug effects in Koreans.
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Frequency distribution of the combined genotypes for the *GSTM1*, *GSTT1* and *GSTP1* polymorphism
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Frequencies of the homozygous deletions at *GSTM1*, *GSTT1* loci and their combination in present study, in comparison with those on other studies in Koreans and other populations
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Frequencies of *GSTP1* polymorphisms in the present study, in comparison those in other studies on Koreans and other populations
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